dr. patel discusses impact of immunotherapy on nsclc
Published 6 years ago • 121 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:10
dr. patel on immunotherapy landscape of stage iv nsclc
-
1:14
dr. patel on choosing immunotherapy drugs for nsclc
-
1:10
dr. patel on primary and adaptive resistance to immunotherapy in nsclc
-
1:58
dr. patel on combination chemotherapy and immunotherapy in lung cancer
-
2:18
dr. patel on immunotherapy combinations in lung cancer
-
0:54
dr. morgensztern on impact of immunotherapy on nsclc field
-
2:05
lung cancer video library - combinations of immunotherapy agents in advanced nsclc: current status
-
0:15
copy of dr. patel on novel agents for patients with nsclc
-
0:57
dr. patel on the fda approval of durvalumab in nsclc
-
1:33
dr. patel on treatment considerations in advanced squamous nsclc
-
1:42
dr. carbone on the impact of immunotherapy in lung cancer
-
1:25
dr. paulson discusses acquired resistance to immunotherapy
-
1:00
chemotherapy and immunotherapy combinations are the future of nsclc treatment
-
5:43
duration of upfront immunotherapy for nsclc
-
1:15
dr. langer on the impact of frontline immunotherapy in lung cancer
-
1:49
dr. jahanzeb on immunotherapy in elderly patients with nsclc
-
1:35
dr. patel on novel agents for patients with nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:19
dr. sabari on biomarkers of response to immunotherapy in advanced nsclc